CareChex, a division of Comparion Medical Analytics, released a new study which identifies the nation’s highest quality health systems for providing cardiac services. The study analyzed three years of data from the Centers for Medicare and Medicaid Services (CMS) and the Agency for Healthcare Research and Quality (AHRQ) using the company's patent-pending quality rating methodology. The methodology evaluates hospital adherence to clinical processes which represent the best standard of care and outcome performance on rates of mortality, complications and patient safety events.

In March, Apple announced the launch of ResearchKit, an open source software framework designed for medical and health research. The platform is designed to help doctors and scientists gather data more frequently and more accurately from participants using iPhone apps. World-class research institutions have already developed apps with ResearchKit for studies on asthma, breast cancer, cardiovascular disease, diabetes and Parkinson’s disease. Users decide if they want to participate in a study and how their data is shared.

Royal Philips announced the introduction of HeartModelA.I., a new Anatomically Intelligent Ultrasound (AIUS) tool that brings advanced quantification, automated 3-D views and robust reproducibility to cardiac ultrasound imaging. Philips' fastest 3-D AIUS ultrasound measurement method was unveiled on its Epiq 7 ultrasound system during the American Society of Echocardiography (ASE) annual meeting in Boston.

Researchers announced the results of a study to develop and validate a model, comprised of echocardiographic and clinical data, to predict three-year mortality of patients hospitalized in coronary care units (CCU). The results describe an integrated score for three-year mortality of CCU patients, comprised of fewer variables and better/equal predictive value compared to existing scores.

A research team from New York has announced advances in automated echocardiography decision systems that could help clinicians more accurately assess complex heart disease. The team developed a system that takes a large amount of information from ultrasound images, learns about the structure and function of the heart, and automatically differentiates enlarged hearts seen in patients with hypertrophic cardiomyopathy (HCM) from a normal variation of enlarged hearts seen in athletes. The two conditions are often difficult to distinguish from each other, and misdiagnoses might have major implications, since undiagnosed HCM is one of the most common causes of sudden cardiac death in athletes, while thickening seen in athlete's heart is benign and does not generally lead to dysfunction.

Researchers announced results of a new study which demonstrated that smartphone-based mHealth devices, coupled with handheld echocardiography, can provide improved assessment and are readily integrated at the point-of-care for evaluation of patients with structural heart diseases. This study was conducted as part of the American Society of Echocardiography (ASE) Foundation's Valvular Assessment Leading to Unexplored Echocardiographic Stratagems (VALUES) program, a four-day teaching and research event held at the Sri Sathya Sai Institute of Higher Medical Sciences in Bangalore, India, August 11-14, 2014. Over the course of several days, researchers assessed patients with multiple forms of rheumatic valvular heart disease with either standard diagnostic equipment or mobile health-based devices.

June 12, 2015 — Fujifilm Medical Systems U.S.A. Inc. will demonstrate the latest generation of Synapse Cardiovascular version 6.0 at the American Society of Echocardiography (ASE) 26th Annual Scientific Sessions, June 13 – 15 in Boston. Synapse Cardiovascular version 6.0 is a total re-engineering of Fujifilm’s solution for echo reporting.

Subscribe Now